Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "ERO1L"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer
So-Young Seol, Chul Kim, Jae Yun Lim, Sun Och Yoon, Soon Won Hong, Jong Won Kim, Seung Ho Choi, Jae Yong Cho
Cancer Res Treat. 2016;48(4):1196-1209.   Published online February 26, 2016
DOI: https://doi.org/10.4143/crt.2015.189
AbstractAbstract PDFPubReaderePub
Purpose
Gastric cancer is the second leading cause of cancer-related death worldwide. Although surgery is the standard curative treatment for gastric cancer, relapse occurs in a large number of patients, except in the case of early diagnosed gastric cancer. Following previous studies that identified endoplasmic reticulum oxidoreductin 1-α (ERO1L) as a potential marker for gastric cancer, we investigated the functional role of ERO1L in gastric cancer.
Materials and Methods
For validation of microarray data, the mRNA expression level of ERO1L was measured by quantitative real-time reverse transcription polymerase chain reaction in 56 independent stage III gastric cancer patients. Immunohistochemical staining was performed to examine the protein expression level of ERO1L in 231 gastric cancer patients. Correlation between gene expression and cancer prognosis was evaluated.
Results
Patients with high ERO1L expression had poorer survival than those with low expression (p < 0.01). Functional assays demonstrated that ERO1L knockdown inhibited cell proliferation, migration, invasion, and chemoresistance. In addition, involvement of inactivation of Akt and JNK signaling in molecular mechanisms of ERO1L inhibition was demonstrated.
Conclusion
High expression of ERO1L is associated with poor prognosis of patients with gastric cancer. These results indicate that ERO1L expression may be a clinically promising therapeutic target for prevention of gastric cancer.

Citations

Citations to this article as recorded by  
  • Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer
    Peng Chen, Amit Sharma, Hans Weiher, Ingo G.H. Schmidt-Wolf
    Journal of Experimental & Clinical Cancer Research.2024;[Epub]     CrossRef
  • Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma
    Xuebing Zhou, Yuan Li, Chunyu Yang, Dan Chen, Tong Wang, Tesi Liu, Wendi Yan, Zhaoxia Su, Bosen Peng, Xiangshan Ren
    Life Sciences.2023; 327: 121698.     CrossRef
  • ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway
    Min Wu, Ruixue Li, Jianyan Qin, Ziyuan Wang, Jiasen Guo, Fenghong Lv, Guoqin Wang, Youguang Huang
    Journal of Molecular Histology.2023; 54(6): 621.     CrossRef
  • Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studies
    Hussam Albassam, Chetan H. Mehta, Usha Y. Nayak
    Journal of Biomolecular Structure and Dynamics.2022; 40(23): 13218.     CrossRef
  • MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha
    Gang Chen, Qihao Wang, Kunyu Wang
    Bioengineered.2022; 13(4): 10061.     CrossRef
  • ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β‐catenin signaling pathway
    Jinbao Xie, Guoliang Liao, Zhi Feng, Bo Liu, Xu Li, Minglian Qiu
    Molecular Carcinogenesis.2022; 61(10): 897.     CrossRef
  • Current therapeutic options for gastric adenocarcinoma
    C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
    Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
  • circ‑ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR‑582‑5p/ERO1A signaling axis
    Dandan Huang, Cuimei Li
    Oncology Letters.2021;[Epub]     CrossRef
  • Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
    Li Li, Xiaodong Yin, Hai Meng, Juanyu Hu, Zhengqing Yu, Jianyong Xu
    Yonsei Medical Journal.2020; 61(1): 15.     CrossRef
  • Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities
    Zifeng Song, Martin C. Pearce, Yuan Jiang, Liping Yang, Cheri Goodall, Cristobal L. Miranda, Milan Milovancev, Shay Bracha, Siva K. Kolluri, Claudia S. Maier
    Scientific Reports.2020;[Epub]     CrossRef
  • Role of the ERO1-PDI interaction in oxidative protein folding and disease
    Andrea G. Shergalis, Shuai Hu, Armand Bankhead, Nouri Neamati
    Pharmacology & Therapeutics.2020; 210: 107525.     CrossRef
  • Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
    Qing Tao, Wen Zhu, Xiaohui Zhao, Mei Li, Yongqian Shu, Deqiang Wang, Xiaoqin Li
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • ERO1L promotes NSCLC development by modulating cell cycle‐related molecules
    Xiujuan Shi, Jiawen Wu, Yi Liu, Yuxiong Jiang, Changjiang Zhi, Jue Li
    Cell Biology International.2020; 44(12): 2473.     CrossRef
  • ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells
    Yuanyuan lei, Ruochuan Zang, Zhiliang Lu, Guochao Zhang, Jianbing Huang, Chengming Liu, Zhanyu Wang, Shuangshuang Mao, Yun Che, Xinfeng Wang, Sufei Zheng, Lingling Fang, Nan Sun, Jie He
    Cell Death & Disease.2020;[Epub]     CrossRef
  • Hypoxia and Reactive Oxygen Species as Modulators of Endoplasmic Reticulum and Golgi Homeostasis
    Daniela Mennerich, Sakari Kellokumpu, Thomas Kietzmann
    Antioxidants & Redox Signaling.2019; 30(1): 113.     CrossRef
  • Endoplasmic reticulum proteostasis control and gastric cancer
    Yu Wang, Kai Wang, Yang Jin, Xia Sheng
    Cancer Letters.2019; 449: 263.     CrossRef
  • Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions
    Ruitang Shi, Haoqing Yang, Xiao Lin, Yangyang Cao, Chen Zhang, Zhipeng Fan, Benxiang Hou
    Stem Cell Research & Therapy.2019;[Epub]     CrossRef
  • A2ML1and otitis media: novel variants, differential expression, and relevant pathways
    Eric D. Larson, Jose Pedrito M. Magno, Matthew J. Steritz, Erasmo Gonzalo d.V. Llanes, Jonathan Cardwell, Melquiadesa Pedro, Tori Bootpetch Roberts, Elisabet Einarsdottir, Rose Anne Q. Rosanes, Christopher Greenlee, Rachel Ann P. Santos, Ayesha Yousaf, Sv
    Human Mutation.2019;[Epub]     CrossRef
  • ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
    Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Olga L. Kardymon, Maria V. Savvateeva, Nataliya V. Melnikova, George S. Krasnov, Alexey A. Dmitriev
    Oxidative Medicine and Cellular Longevity.2019; 2019: 1.     CrossRef
  • Control of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges
    Daria Sicari, Aeid Igbaria, Eric Chevet
    Cells.2019; 8(11): 1347.     CrossRef
  • ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
    Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, Siu Kwan Sze
    Oncotarget.2019; 10(57): 5970.     CrossRef
  • Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology
    Olga A. Smirnova, Birke Bartosch, Natalia F. Zakirova, Sergey N. Kochetkov, Alexander V. Ivanov
    International Journal of Molecular Sciences.2018; 19(4): 1219.     CrossRef
  • Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1‑α is a poor prognostic marker for non‑small cell lung cancer
    Kyoung Kim, Ae An, Ho Park, Kyu Jang, Woo Moon, Myoung Kang, Yong Lee, Ja Ku, Myoung Chung
    Oncology Letters.2018;[Epub]     CrossRef
  • High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence
    Toshio Sakatani, Keita Maemura, Noriko Hiyama, Yosuke Amano, Kousuke Watanabe, Hidenori Kage, Masashi Fukayama, Jun Nakajima, Yutaka Yatomi, Takahide Nagase, Daiya Takai
    Japanese Journal of Clinical Oncology.2017; 47(6): 543.     CrossRef
  • Omics technologies in diagnostics of lung adenocarcinoma
    S.E. Novikova, L.K. Kurbatov, M.G. Zavialova, V.G. Zgoda, A.I. Archakov
    Biomeditsinskaya Khimiya.2017; 63(3): 181.     CrossRef
  • Omics technologies in diagnosis of lung adenocarcinoma
    S. E. Novikova, L. K. Kurbatov, M. G. Zavialova, V. G. Zgoda, A. I. Archakov
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.2017; 11(4): 309.     CrossRef
  • Expression of ERO1L in gastric cancer and its association with patient prognosis
    Bo Zhou, Gongping Wang, Shegan Gao, Ye Chen, Canhui Jin, Zengfang Wang, Yantong Yang, Zhikun Ma, Wei Zhang, Xiaoshan Feng
    Experimental and Therapeutic Medicine.2017; 14(3): 2298.     CrossRef
  • Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
    Hongzhe Li, Xinjing Wang, Yuan Fang, Zhen Huo, Xiongxiong Lu, Xi Zhan, Xiaxin Deng, Chenghong Peng, Baiyong Shen
    Oncotarget.2017; 8(32): 52571.     CrossRef
  • 13,053 View
  • 218 Download
  • 28 Web of Science
  • 28 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP